Literature DB >> 10367696

Idiopathic blepharospasm does not lead to a parkinsonian syndrome: results of a questionnaire-based follow-up study.

N Soonawala1, K P Bhatia, J H Yeung, N P Quinn, C D Marsden.   

Abstract

It has been suggested that a lesion in the dopaminergic neurons of the substantia nigra pars compacta combined with eye irritation is involved in the pathophysiology of idiopathic blepharospasm. If so, these patients might be prone to develop Parkinson's disease or a parkinsonian syndrome. We therefore conducted a validated questionnaire-based follow-up study to estimate (a) the frequency of local eye disorders at onset and (b) frequency of development of parkinsonian symptoms in blepharospasm patients. Ninety-nine patients previously diagnosed with idiopathic blepharospasm were sent a two-part questionnaire to assess parkinsonian and other symptoms associated with their condition. The average period of follow-up was 12.7 years, ranging from 3 to 26 years, with an average age at onset of 53.5 years. Sixty-two patients reported other ocular symptoms prior to or at the onset of blepharospasm, and therefore ocular disease may act as a trigger to produce blepharospasm in those already predisposed. Only two patients had developed a score on the parkinsonism rating scale indicating possible Parkinson's disease, but clinical examination confirmed this not to be the case. If a lesion in the dopaminergic neurons is involved in blepharospasm, it would appear to be relatively minor (and non-progressive), since patients with idiopathic blepharospasm do not seem prone to develop parkinsonian symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367696     DOI: 10.1007/s004150050347

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism.

Authors:  Won Tae Yoon; Eun Joo Chung; Sang Hyeon Lee; Byung Joon Kim; Won Yong Lee
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

Review 2.  Dystonia in Parkinson's disease.

Authors:  Eduardo Tolosa; Yaroslau Compta
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

3.  Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease.

Authors:  Qian-Ya Fan; Xiao-Dong Zhang; Ze-Di Hu; Shi-Shi Huang; Shi-Guo Zhu; Cai-Ping Chen; Xiong Zhang; Jian-Yong Wang
Journal:  Front Neurol       Date:  2022-09-30       Impact factor: 4.086

4.  Animal models for investigating benign essential blepharospasm.

Authors:  Craig Evinger
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.